BioDot Signs Distribution Agreement with CapitalBio

Share Article

CapitalBio has a broad product offering and expertise in the biochip arena which will compliment BioDot's quantitative, non contact dispensing.


“The agreement is truly synergistic”, stated Guangwei Fan, Sales Manager at CapitalBio, “as we are now able to expand our applications focus into markets such as Lateral Flow, where BioDot is a leader”.

BioDot signs new distribution agreement with CapitalBio.

Under the terms of the agreement, CapitalBio can promote and sell BioDot products outside of the Shanghai province specific to government accounts such as the Center of Disease Control and the Inspection and Quarantine facilities.

In addition, CapitalBio and BioDot have agreed to work together to position both companies products for complete range of biochip and molecular diagnostic applications.

Tom Tisone, President of BioDot commented that “with CapitalBio's extensive sales force, the agreement will give BioDot China support into regions where we don't have coverage.”


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Barbara McIntosh, VP Sales & Marketing
Email >
Visit website